Inventor
Greg Elson
Inventor
Collonges sous Saleve, FR
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,982,004Anti-TLR4 antibodies and uses thereof202110,844,132Neutralizing antibodies and methods of use thereof202010,759,862Anti-IL-6/IL-6R antibodies and methods of use thereof202010,759,858Anti-CD3 antibodies and methods of use thereof202010,689,441Anti--TLR4 antibodies and methods of use thereof202010,597,465Methods for the generation of multispecific and multivalent antibodies202010,556,960Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers202010,400,044Anti-TLR4 antibodies and uses thereof201910,047,144Methods of purifying antibodies201810,023,646Neutralizing antibodies and methods of use thereof20189,926,382'Methods for the generation of multispecific and multivalent antibodies'20189,850,304Anti-CD3 antibodies and methods of use thereof20179,834,615Methods for the generation of multispecific and multivalent antibodies20179,828,430Anti-IL-6/IL-6R antibodies20179,688,769'Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers'20179,688,755'Fc receptor-binding polypeptides with modified effector functions'20179,682,142'Anti-interferon gamma antibodies and methods of use thereof'20179,540,444'Neutralizing antibodies and methods of use thereof'20179,534,049'Neutralizing antibodies and methods of use thereof'20179,453,076'Anti-TLR4 antibodies and uses thereof'20169,234,034'Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies'20168,617,880'Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof'20138,609,822'Neutralizing antibodies and methods of use thereof'20138,551,478'Anti-CD3 antibodies and methods of use thereof'20138,546,539'Fc receptor-binding polypeptides with modified effector functions'20138,337,849'Anti-IL6/IL-6R antibodies'20128,105,595'Methods of using neutralizing anti-TLR4/MD2 antibodies'20128,106,018'Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof'20128,034,344'Anti-IL-6/IL-6R antibodies and methods of use thereof'20118,029,794'Combining therapies targeting multiple toll-like receptors'20117,744,884'Neutralizing antibodies and methods of use thereof'20107,728,114'Anti-CD3 antibodies and methods of use thereof'20107,700,098'Anti-interferon gamma antibodies and methods of use thereof'20107,674,884'Neutralizing antibodies and methods of use thereof'20107,312,320'Neutralizing antibodies and methods of use thereof'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2021Patents assigned to NOVIMMUNE SA (35)· patent assignee history
2007–2021Based in Collonges sous Saleve, FR· patent location history
2012–2017Patents assigned to ELSON GREG (8)· patent assignee history
2012–2013Patents assigned to LEGER OLIVIER (5)· patent assignee history
2012–2013Patents assigned to KOSCO-VILBOIS MARIE (2)· patent assignee history
2013–2017Patents assigned to FISCHER NICOLAS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVIMMUNE SA | 35 | 2007–2021 |
| ELSON GREGself | 8 | 2012–2017 |
| LEGER OLIVIER | 5 | 2012–2013 |
| FISCHER NICOLAS | 2 | 2013–2017 |
| KOSCO-VILBOIS MARIE | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Collonges sous Saleve, FR | 35 | 2007–2021 |